Denali Therapeutics Inc. (FRA:4DN)
17.19
+1.14 (7.11%)
At close: Feb 20, 2026
-17.06% (1Y)
| Market Cap | 2.68B -17.9% |
| Revenue (ttm) | n/a |
| Net Income | -425.08M |
| EPS | -2.48 |
| Shares Out | n/a |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | n/a |
| Average Volume | 30 |
| Open | 17.19 |
| Previous Close | 16.05 |
| Day's Range | 17.19 - 17.19 |
| 52-Week Range | 10.17 - 21.14 |
| Beta | n/a |
| RSI | 55.33 |
| Earnings Date | Feb 27, 2026 |